<p>Receiver operation characteristic analysis using serum caspase-cleaved cytokeratin (CCCK)-18 levels as predictor of mortality at 30 days.</p
<p>Receiver operating characteristic curve of clinical scores and their ability to predict 30-day mo...
Receiver operating characteristic curve analysis for predicting RBC transfusion within 28 days.</p
BackgroundTumor cell death generates products that can be measured in the circulation of cancer pati...
<p>Receiver operating characteristic analysis using serum caspase-cleaved cytokeratin (CCCK)-18 leve...
<p>Receiver operation characteristic analysis using TIMP-1 serum levels as predictor of mortality at...
<p>Survival curves at 30 days using serum caspase-cleaved cytokeratin (CCCK)-18 levels higher or low...
<p>Survival curves at 30 days using serum caspase-cleaved citokeratin (CCCK)-18 levels higher or low...
<p>Receiver operation characteristic analysis using MDA serum levels as predictor of mortality at 30...
<p>Receiver operation characteristic analyses using TIMP-1/MMP-9 ratio at day 1, 4 and 8 after admis...
Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte ap...
Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte ap...
<p>Receive operating characteristic analysis of age(years) and admission serum Cr level(µmol/l) in p...
<p>GCS Glasgow Coma Scale; CCCK = caspase-cleaved cytokeratin; APACHE II = Acute Physiology and Chro...
<p>Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) f...
<p>CCCK = caspase-cleaved citokeratin; SOFA = Sepsis-related Organ Failure Assessment.</p><p>Multipl...
<p>Receiver operating characteristic curve of clinical scores and their ability to predict 30-day mo...
Receiver operating characteristic curve analysis for predicting RBC transfusion within 28 days.</p
BackgroundTumor cell death generates products that can be measured in the circulation of cancer pati...
<p>Receiver operating characteristic analysis using serum caspase-cleaved cytokeratin (CCCK)-18 leve...
<p>Receiver operation characteristic analysis using TIMP-1 serum levels as predictor of mortality at...
<p>Survival curves at 30 days using serum caspase-cleaved cytokeratin (CCCK)-18 levels higher or low...
<p>Survival curves at 30 days using serum caspase-cleaved citokeratin (CCCK)-18 levels higher or low...
<p>Receiver operation characteristic analysis using MDA serum levels as predictor of mortality at 30...
<p>Receiver operation characteristic analyses using TIMP-1/MMP-9 ratio at day 1, 4 and 8 after admis...
Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte ap...
Cytokeratin (CK)-18 is the major intermediate filament protein in the liver and during hepatocyte ap...
<p>Receive operating characteristic analysis of age(years) and admission serum Cr level(µmol/l) in p...
<p>GCS Glasgow Coma Scale; CCCK = caspase-cleaved cytokeratin; APACHE II = Acute Physiology and Chro...
<p>Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) f...
<p>CCCK = caspase-cleaved citokeratin; SOFA = Sepsis-related Organ Failure Assessment.</p><p>Multipl...
<p>Receiver operating characteristic curve of clinical scores and their ability to predict 30-day mo...
Receiver operating characteristic curve analysis for predicting RBC transfusion within 28 days.</p
BackgroundTumor cell death generates products that can be measured in the circulation of cancer pati...